Arq Bras Cardiol
September 2024
Background: The analysis of indicators such as hospital readmission rates is crucial for improving the quality of services and management of hospital processes.
Objectives: To identify the variables correlated with hospital readmission up to 30 days following coronary artery bypass grafting (CABG).
Methods: Cross-sectional cohort study by REPLICCAR II database (N=3,392) from June 2017 to June 2019.
Arq Bras Cardiol
August 2024
Background: Analyses of extensive registries indicate adverse outcomes for women undergoing coronary artery bypass grafting (CABG) surgery, while randomized studies often lack representativeness.
Objective: To compare adjusted hospital outcomes between men and women undergoing CABG.
Methods: From July 2017 to June 2019, 3991 patients underwent primary isolated CABG, both electively and urgently, in 5 hospitals in the state of São Paulo, Brazil.
Arq Bras Cardiol
June 2024
Background: Identifying risk factors in cardiovascular surgery assists in predictability, resulting in optimization of outcomes and cost reduction.
Objective: This study aimed to identify preoperative and intraoperative risk predictors for prolonged hospitalization after coronary artery bypass grafting (CABG) surgery in the state of São Paulo, Brazil.
Methods: A cross-sectional analysis using data from the REPLICCAR II database, a prospective, consecutive, multicenter registry that included CABG surgeries performed between August 2017 and July 2019.
Objectives: The aim of this study was to evaluate the efficacy of perioperative intra-aortic balloon pump use in high-risk cardiac surgery patients.
Design: A single-center randomized controlled trial and a meta-analysis of randomized controlled trials.
Setting: Heart Institute of São Paulo University.
Background: Vasoplegic syndrome is a common complication after cardiac surgery and impacts negatively on patient outcomes. The objective of this study was to evaluate whether vasopressin is superior to norepinephrine in reducing postoperative complications in patients with vasoplegic syndrome.
Methods: This prospective, randomized, double-blind trial was conducted at the Heart Institute, University of Sao Paulo, Sao Paulo, Brazil, between January 2012 and March 2014.